We are pleased to announce that the Journal of Thoracic Disease (JTD) has attained its latest impact factor update for the 2023 citation year: 2.1 (Figure 1).
Figure 1. 2023 Impact Factor of JTD.
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) is an international, peer-reviewed, open-access journal, which was founded in Dec 2009. JTD is indexed by Science Citation Index Expanded (SCIE), PubMed/PubMed Central, and Scopus. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to the thoracic disease.
The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.
We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in thoracic disease to bring more exciting content to readers in the coming future.
Editorial Office
Journal of Thoracic Disease
June 20, 2024